The objectives of this study were to further characterize the effects
of a chronic lithium (Li+) treatment on seratonin (5-HT) uptake sites,
and to determine the eventual reversibility of the observed effects.
Quantitative autoradiography experiments were carried out on sections
from rat brain, using [H-3]citalopram to label selectively the 5-HT tr
ansporters or uptake sites. In these experiments, we were able to satu
rate the 5-HT transporters using an isotopic dilution of the radioliga
nd. The lowest densities of [H-3]citalopram binding were measured in a
ll cortical regions studied, with the highest cortical labelling in th
e anterior cingulate cortex. The rostral neostriatum presented a moder
ate density of labelling, with slightly higher levels in its ventral p
ortion. Relatively high densities were measured in the globus pallidus
, hippocampus, and hypothalamus. Finally, the highest densities were f
ound in the brain stem. Indeed, the dorsal raphe nuclei as well as the
substantia nigra were characterized by very high amounts of [H-3]cita
lopram binding. The chronic administration of Li+ increased the densit
y of 5-HT uptake sites in cortical regions, and significant difference
s were observed in the frontal, temporal, and entorhinal-piriform cort
ices, with an elevation, albeit not significant, in the anterior cingu
late region. A significant increase was also observed in the lateral h
ypothalamus. Since the 5-HT uptake sites were studied with saturating
concentrations of citalopram, we can propose that this increase in bin
ding densities can be attributed to an increase in the number of 5-HT
transporters. Interestingly the only modifications observed were locat
ed in regions containing nerve terminals of 5-HT neurons, while region
s with cell bodies remained unaffected. Moreover, these effects were c
ompletely reversed following a recovery of 48 h without Li+. Also, the
re were no modifications in the density of 5-HT uptake sites after onl
y 2 days of Li+. These results, suggesting an anatomically heterogenou
s increase in 5-HT uptake in chronically treated rats, are in accord w
ith clinical observations and previous reports with homogenate binding
assays. Finally, the conclusions from this study further support the
importance of central 5-HT synaptic transmission in the pathophysiolog
y and treatment of human affective disorders. (C) 1997 Wiley-Liss, Inc
.